1. Market Research
  2. > Pathology
14 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Umbilical Cord Blood Banking Market Research Report by Storage, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 86 pages

Lymphoma ##. ##.

  • Lymphoma
  • Medical Biotechnology
  • United States
  • Market Size

Oral Cancer Treatment Market Research Report by Product Type, by Treatment, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 93 pages

Lymphomas ##. ##.

  • Lymphoma
  • Oropharynx Cancer
  • Therapy
  • United States
  • Market Size

Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025

  • $ 3500
  • August 2020
  • 266 pages

IN MAY 2018, THE PRODUCT RECEIVED EXPANDED INDICATION APPROVAL FOR B-CELL LYMPHOMA.

  • Gene Therapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Non-Hodgkin Lymphoma Treatment Market Research Report by Treatment, by Cell Type - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 87 pages

Non-Hodgkin Lymphoma Treatment Market Research Report by Treatment, by Cell Type - United States Forecast to 2025 - Cumulative Impact of COVID-## ##.

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • United States
  • Market Size

Prescription Drugs Companies in China

  • $ 1800
  • July 2020
  • 73 pages

Experience from basic research and long term clinical application has shown that KLT presents good effect in treatment of cancers mainly at sites of lung, liver, stomach, breast, prostate and malignant lymphoma, etc.

  • Lymphoma
  • Pharmaceutical
  • Prescription Drug
  • China
  • Zhejiang Expressway Co., Ltd.

Prescription Drugs Markets in China

  • $ 4000
  • July 2020
  • 217 pages

Experience from basic research and long term clinical application has shown that KLT presents good effect in treatment of cancers mainly at sites of lung, liver, stomach, breast, prostate and malignant lymphoma, etc.

  • Lymphoma
  • Pharmaceutical
  • Prescription Drug
  • China
  • Demand

Hemato Oncology Testing Market Research Report by Products & Services, by Cancer, by Technology, by End-User - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • $ 1449
  • July 2020
  • 85 pages

Hemato Oncology Testing Market Research Report by Products & Services, by Cancer, by Technology, by End-User - United States Forecast to 2025 - Cumulative Impact of COVID-## ##.

  • Cancer
  • Lymphoma
  • United States
  • Forecast

2024 POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies, Opportunities

  • $ 7500
  • July 2020
  • 1230 pages

Flow Cytometry Tests Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Functi

  • Diagnostics
  • Infectious Disease
  • Lymphoma
  • Pathology
  • Therapy

Antibody Drug Conjugates (ADCs)-Linker and Conjugation Technologies Market, 2019-2030

  • $ 4499
  • November 2020
  • 310 pages

Leukemia & Lymphoma Society ##.

  • Lymphoma
  • APAC
  • North America
  • United States

Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

  • $ 1800
  • July 2020
  • 128 pages

CD##β Humanized IgG## ADC Hybridoma Diffuse large Bcell lymphoma Brolucizumab Beovu Novartis Pharmaceuticals Corp.

  • Lymphoma
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Market Size

United States Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others

  • $ 5995
  • August 2020
  • 731 pages

HIGHLIGHTS OF THE ME-## UPDATED DATA INCLUDE: LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA (CLL/ SLL).

  • Hospital
  • Lymphoma
  • Wound Care
  • North America
  • United States

France Wound Care Management Market Outlook to 2025 - Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others

  • $ 5995
  • August 2020
  • 356 pages

The ongoing combination trials in Multiple Myeloma and Lymphoma as well as combination trials with isatuximab and atezolizumab in solid tumors continue.

  • Lymphoma
  • Medical Supply
  • Wound Care
  • France
  • Western Europe


View report >

AstraZeneca PLC - Analyst Report, July 2020

  • July 2020
  • 11 pages

IN NOVEMBER 2017, ANOTHER CANCER DRUG CALQUENCE (ACALABRUTINIB) GAINED FDA APPROVAL FOR PREVIOUSLY TREATED MANTLE CELL LYMPHOMA (MCL), THE FIRST FOR ASTRAZENECA FOR A TYPE OF BLOOD CANCER.

  • Lymphoma
  • Pathology
  • Therapy
  • Demand
  • AstraZeneca PLC

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on